TB500 (Fragment)
Thymosin fragment sold in research-chemical markets; high-quality human evidence for this fragment form is not established.
goal:recovery-sorenessgoal:muscle-recoverygoal:jointsconstraint:not-drug-test-safeevidence:very-lowstudy:other-unclearpop:other-unclearform:other
Dosing model
FLATFixed dose (no body-weight scaling).
Min dose
—
Max dose
—
Rounding
—
Stacks containing TB500 (Fragment)
Public community stacks that include this ingredient.
No public stacks include this ingredient yet.
Evidence
1 record
Tissue repair plausibility
Other/unclear • Other/unclear
Do not assume equivalence to full-length TB4 evidence; robust fragment-specific clinical trials are not established in mainstream literature.
Dose: —
Citation: Evidence not clearly established for marketed TB500 fragment products
Forms
Lyophilized powder
Research material (vendor listing)